Masaru Taniguchi

Masaru Taniguchi

Auto-generated profile, based on publicly available information

Masaru Taniguchi

Nagoya City Public Health Research Institute, 4-207 Sakurazaka, Moriyama-ku, Nagoya 463-8585, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Food Control
Verified
Journal Article
Closed access
TYTomoya Yoshinari
Tomoya Yoshinari
YSYoshiko Sugita-Konishi
Yoshiko Sugita-Konishi
ESEiko Sato
Eiko Sato
HTHiroshi Takeuchi
Hiroshi Takeuchi
MTMasaru Taniguchi
Masaru Taniguchi
YHYukiko Hara-Kudo
Yukiko Hara-Kudo

29 June 2022 in ACS Omega
Verified
Journal Article
Open access
KZKei Zaitsu
Kei Zaitsu
TATomomi Asano
Tomomi Asano
DKDaisuke Kawakami
Daisuke Kawakami
JCJiarui Chang
Jiarui Chang
KHKazuaki Hisatsune
Kazuaki Hisatsune
AIAkira Iguchi
Akira Iguchi
We performed serum metabolome analysis of di­(2-ethylhexyl)­phthalate (DEHP)-exposed and control pregnant mice. Pregnant mice (n = 5) were fed a DEHP-containing diet (0.1% or 0.2% DEHP) or a normal diet (control) from gestational days 0–18. After maternal exposure to 0.2% DEHP there were no surviving fetuses, indicating its strong fetal lethality. There were no significant differences in the numbers of fetuses and placentas between the 0.1% DEHP and control groups, although fetal viability differed significantly between them, suggesting that maternal exposure to 0.1% DEHP could inhibit fetal growth. Metabolomics successfully detected 169 metabolites in serum. Principal component analysis (PCA) demonstrated that the three groups were clearly separated on PCA score plots. The biological interpretation of PC1 was fetal lethality, whereas PC2 meant metabolic alteration of pregnant mice via DEHP exposure without fetal lethality. In particular, the first component was significantly correlated with fetal viability, demonstrating that maternal metabolome changes via DEHP exposure were strongly related to fetal lethality. Levels of some amino acids were significantly increased in the DEHP-exposed groups, whereas those of some fatty acids, nicotinic acid, and 1,5-anhydroglucitol were significantly decreased in the DEHP groups. DEHP-induced increases in glycine levels could cause fetal neurological disorders, and decreases in nicotinic acid could inhibit fetal growth. In addition, a machine-learning Random forest could determine 16 potential biomarkers of DEHP exposure, and data-driven network analysis revealed that nicotinic acid was the most influential hub metabolite in the metabolic network. These findings will be useful for understanding the effects of DEHP on the maternal metabolome in pregnancy and their relationship to fetal lethality.

1 January 2021 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MTMasaru Taniguchi
Masaru Taniguchi
TMTomiaki Minatani
Tomiaki Minatani
HMHitoshi Miyazaki
Hitoshi Miyazaki
HTHitoshi Tsuchihashi
Hitoshi Tsuchihashi
KZKei Zaitsu
Kei Zaitsu

29 October 2022 in Chromatographia
Verified
Journal Article
Closed access
PDF file
MTMasaru Taniguchi
Masaru Taniguchi
NTNaoki Takamura
Naoki Takamura
TWTsutomu Watanabe
Tsutomu Watanabe
RIReiko Ishimaru
Reiko Ishimaru
SCSatoshi Chinaka
Satoshi Chinaka
KZKei Zaitsu
Kei Zaitsu

25 February 2025 in Food Control
Verified
Journal Article
Closed access
MTMasaru Taniguchi
Masaru Taniguchi
SNShoichiro Noguchi
Shoichiro Noguchi
HKHidenobu Kawashima
Hidenobu Kawashima
JSJun Sugiura
Jun Sugiura
TTTomoyuki Tsuchiyama
Tomoyuki Tsuchiyama
KZKei Zaitsu
Kei Zaitsu

30 November 2025 in Journal of Proteome Research
Verified
Journal Article
Closed access
SSShinnosuke Sugiura
Shinnosuke Sugiura
MTMasaru Taniguchi
Masaru Taniguchi
TKTomoki Kakei
Tomoki Kakei
YOYuto Ohtani
Yuto Ohtani
YHYumi Hayashi
Yumi Hayashi
KZKei Zaitsu
Kei Zaitsu